Atlas Trials

Combination of Hypofractionated Proton Therapy With Immunotherapy

Clinical trial NCT03764787 · UNKNOWN

Trial details

NCT number
NCT03764787
Sponsor
Peking University First Hospital
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Proton TherapyImmunotherapy
Start date
2019-01-01
Primary completion
2021-01-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.